Fosfomycin is NOT Recommended for Male UTI
Fosfomycin should not be used for treating uncomplicated lower urinary tract infections in men. The most recent 2024 European Association of Urology (EAU) guidelines explicitly state that fosfomycin trometamol is "recommended only in women with uncomplicated cystitis," and the FDA drug label clearly indicates it is "only for the treatment of uncomplicated urinary tract infections (acute cystitis) in women" 1, 2.
Why Men Are Excluded
The fundamental issue is that UTIs in men are inherently considered complicated infections due to anatomical and physiological differences. The EAU guidelines define uncomplicated cystitis as being "limited to nonpregnant women with no known relevant anatomic or functional abnormalities" 1. Men are categorically excluded from this definition because:
- Male UTIs often involve prostatic involvement, even when presenting as simple cystitis
- The longer male urethra and prostatic anatomy create different pharmacokinetic requirements
- Single-dose therapy (fosfomycin's hallmark) has not been adequately studied or validated in men
What to Use Instead for Male UTI
For men with lower UTI, use trimethoprim-sulfamethoxazole 160/800 mg twice daily for 7 days 1. The EAU guidelines specifically designate this as the treatment regimen "restricted to men," with fluoroquinolones as an alternative based on local susceptibility patterns.
The 7-day duration (versus 3 days in women) accounts for:
- Potential subclinical prostatic involvement
- Need for adequate tissue penetration
- Higher risk of treatment failure with shorter courses
Critical Clinical Pitfall
Do not be misled by fosfomycin's excellent activity against E. coli (96% susceptibility rates globally) 3 or its convenience as single-dose therapy. The lack of clinical trial data in men, combined with regulatory restrictions and guideline exclusions, makes this an inappropriate choice regardless of in vitro susceptibility 2, 4.
When Fosfomycin Might Be Considered in Men
The only scenario where fosfomycin appears in male UTI management is for asymptomatic bacteriuria before urological procedures breaching the mucosa, where single-dose fosfomycin trometamol is mentioned as an option 1. However, this is a preventive indication, not treatment of active infection.
Algorithm for Male Lower UTI Treatment
- Confirm diagnosis: Urine culture mandatory in men (unlike women where empiric treatment is acceptable)
- First-line: TMP-SMX 160/800 mg BID × 7 days
- If TMP-SMX contraindicated or local resistance >20%: Fluoroquinolone (ciprofloxacin or levofloxacin) × 7 days based on susceptibility
- If symptoms persist beyond 48 hours: Consider prostatitis and extend treatment to 14+ days
- Never use: Fosfomycin, nitrofurantoin (poor prostatic penetration), or 3-day regimens
The evidence is unequivocal: fosfomycin's role is limited to uncomplicated cystitis in women, and attempting to extrapolate this to men contradicts both regulatory approval and evidence-based guidelines 1, 2.